Clinical Trials Study
Copyright ©The Author(s) 2020.
World J Cardiol. Nov 26, 2020; 12(11): 526-539
Published online Nov 26, 2020. doi: 10.4330/wjc.v12.i11.526
Figure 1
Figure 1 Boolean analysis. A and B: Flow cytometry analysis for the identification of cellular populations using monoclonal antibodies CD45; C: VEGFR2; D: CD34; E: CD133. In all samples, the CD34 expression was weak. CPET: Cardiopulmonary exercise testing; VEGFR2: Vascular endothelial growth factor receptor 2.
Figure 2
Figure 2 Boxplots representing the acute mobilization of each endothelial cellular population before and after a symptom limited maximal cardiopulmonary exercise testing between two severity groups according to the median value of peak oxygen uptake. Group 1: Peak oxygen uptake (VO2) < 18.0 mL/kg/min; Group 2: Peak VO2 ≥ 18.0 mL/kg/min). aP < 0.05 indicates statistically significantly increase.